128 related articles for article (PubMed ID: 14628985)
1. How many subjects with major depressive disorder meet eligibility requirements of an antidepressant efficacy trial?
Keitner GI; Posternak MA; Ryan CE
J Clin Psychiatry; 2003 Sep; 64(9):1091-3. PubMed ID: 14628985
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
[TBL] [Abstract][Full Text] [Related]
3. Have Treatment Studies of Depression Become Even Less Generalizable? Applying the Inclusion and Exclusion Criteria in Placebo-Controlled Antidepressant Efficacy Trials Published over 20 Years to a Clinical Sample.
Zimmerman M; Balling C; Chelminski I; Dalrymple K
Psychother Psychosom; 2019; 88(3):165-170. PubMed ID: 31096246
[TBL] [Abstract][Full Text] [Related]
4. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?
Zimmerman M; Mattia JI; Posternak MA
Am J Psychiatry; 2002 Mar; 159(3):469-73. PubMed ID: 11870014
[TBL] [Abstract][Full Text] [Related]
5. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
[TBL] [Abstract][Full Text] [Related]
6. Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta-analysis of randomized controlled trials.
Sinyor M; Schaffer A; Smart KA; Levitt AJ; Lanctôt KL; Grysman NH
J Clin Psychiatry; 2012 Feb; 73(2):e277-87. PubMed ID: 22401489
[TBL] [Abstract][Full Text] [Related]
7. Has the symptom severity inclusion requirement narrowed the definition of major depressive disorder in antidepressant efficacy trials?
Zimmerman M; Walsh E; Chelminski I; Dalrymple K
J Affect Disord; 2017 Mar; 211():60-64. PubMed ID: 28088058
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Antidepressant Debate in the Treatment of Major Depressive Disorder.
Naudet F; Boussageon R; Palpacuer C; Gallet L; Reymann JM; Falissard B
Therapie; 2015; 70(4):321-7. PubMed ID: 25679188
[TBL] [Abstract][Full Text] [Related]
9. The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 Years.
Zimmerman M; Holst CG; Clark HL; Multach M; Walsh E; Rosenstein LK; Gazarian D
CNS Drugs; 2016 Dec; 30(12):1209-1218. PubMed ID: 27541608
[TBL] [Abstract][Full Text] [Related]
10. The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice.
van der Lem R; van der Wee NJ; van Veen T; Zitman FG
Psychol Med; 2011 Jul; 41(7):1353-63. PubMed ID: 21078225
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].
Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A
Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial.
Bockting CLH; Klein NS; Elgersma HJ; van Rijsbergen GD; Slofstra C; Ormel J; Buskens E; Dekker J; de Jong PJ; Nolen WA; Schene AH; Hollon SD; Burger H
Lancet Psychiatry; 2018 May; 5(5):401-410. PubMed ID: 29625762
[TBL] [Abstract][Full Text] [Related]
13. Patients excluded from an antidepressant efficacy trial.
Partonen T; Sihvo S; Lönnqvist JK
J Clin Psychiatry; 1996 Dec; 57(12):572-5. PubMed ID: 9010119
[TBL] [Abstract][Full Text] [Related]
14. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
[TBL] [Abstract][Full Text] [Related]
15. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review.
Altshuler L; Kiriakos L; Calcagno J; Goodman R; Gitlin M; Frye M; Mintz J
J Clin Psychiatry; 2001 Aug; 62(8):612-6. PubMed ID: 11561933
[TBL] [Abstract][Full Text] [Related]
16. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
[TBL] [Abstract][Full Text] [Related]
17. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
18. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression.
Papakostas GI; Martinson MA; Fava M; Iovieno N
J Clin Psychiatry; 2016 May; 77(5):e619-24. PubMed ID: 27249092
[TBL] [Abstract][Full Text] [Related]
19. Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials.
Seemüller F; Möller HJ; Obermeier M; Adli M; Bauer M; Kronmüller K; Holsboer F; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Schennach-Wolff R; Henkel V; Riedel M
J Clin Psychiatry; 2010 Nov; 71(11):1425-33. PubMed ID: 20816028
[TBL] [Abstract][Full Text] [Related]
20. Last-observation-carried-forward imputation method in clinical efficacy trials: review of 352 antidepressant studies.
Woolley SB; Cardoni AA; Goethe JW
Pharmacotherapy; 2009 Dec; 29(12):1408-16. PubMed ID: 19947800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
